From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

International Partners Work to Develop Crimean–Congo Hemorrhagic Fever Vaccine

by Global Biodefense Staff
January 24, 2017
Crimean Congo Hemorrhagic Fever Vaccine

The Public Health Agency of Sweden, Karolinska Institutet and the Swedish National Veterinary Institute are leading a new European project to develop a vaccine Crimean–Congo hemorrhagic fever.

The CCHFVaccine project has been given a grant of EUR 6 million through the EU’s Horizon 2020 research program and includes eleven other partners from Europe, the Middle East, Central Asia and the USA.

CCHF is a widespread disease caused by a tick-borne virus (Nairovirus) of the Bunyaviridae family. The CCHF virus causes severe viral haemorrhagic fever outbreaks, with a case fatality rate of 10–40%.

The virus that causes the disease has been given a risk classification of 4, the highest possible for pathogenic agents, and must therefore be handled at the Public Health Agency’s safety laboratory, which is the only one in the Nordic region in the required class.

“Crimean–Congo hemorrhagic fever, or CCHF, is an extremely serious disease that leads, at worst, to internal haemorrhaging and death for about 30 per cent of the people who contract it,” says researcher Ali Mirazimi, who is heading the work to develop a vaccine. “There is currently no specific treatment for the disease and no vaccine to protect against infection.”

From Our Partners
Tags: Crimean-CongoVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC